PHASE III RANDOMIZED STUDY OF SORAFENIB PLUS DOXORUBICIN VERSUS SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

  • Bernicker, Eric H. (Key Personnel)
  • Darcourt, Jorge (Key Personnel)
  • Singh, Monisha (Key Personnel)

Project: Non Profit

Project Details

StatusActive
Effective start/end date8/13/13 → 8/12/38

Funding

  • University of Michigan